Fisher & Paykel Healthcare | FPH - Ebitda

Aktienkurs
28.25
Täglich Wechseln
0.06 0.21%
Monatlich
-10.63%
Jährlich
-17.37%
Q2 Prognose
28.47




Ebitda Veränderung Datum
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Nanosonics AUD 12.49M 1.13M 2025-12
Ramsay Health Care AUD 1.12B 10.6M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Somnomed AUD 764.45K 479.23K 2023-06
Sonic Healthcare AUD 839.07M 51.09M 2024-12